n
a
v
Portfolio
Genetics
AmplideX® Fragile X Dx & Carrier Screen Kit
AmplideX® mPCR FMR1 Kit
AmplideX® PCR/CE FMR1 Kit
AmplideX® FMR1 Controls
Xpansion Interpreter®
AmplideX® PCR/CE
SMN1/2
Plus Kit
AmplideX® PCR/CE
CFTR
Kit
AmplideX® PCR/CE C9orf72 Kit
AmplideX® PCR/CE
DMPK
Kit
AmplideX® PCR/CE
HTT
Kit
AmplideX® TRIO
Oncology
QuantideX® qPCR BCR-ABL IS Kit
QuantideX® qPCR BCR-ABL minor Kit
MolecularDx Controls
Catalog of Armored Products
SARS CoV-2 Controls
Made-To-Order Armored and Nucleic Acid
Molecular Assay Reagents
Custom & Companion Diagnostics
Partnered R&D
CAP-Accredited CLIA Lab
CTA Testing Site
Validated Platforms & Assays
Companion Diagnostics
Enabling Technologies
Assay Chemistries
Bioinformatics
Product Development Process
Resources
Publications
Articles
Whitepapers
Posters
Disease Information
Fragile X
Leukemia
Dementia
Other Resources
Videos
Carrier Screening Guide
Safety Data Sheets
Sales Contacts
Our Culture
Employee Spotlights
Culture & Heritage
Sales Contacts
About
Leadership Team
Culture and Heritage
Press Releases
Upcoming Events
Business Development
Contact
Careers
Search
News
Home
News
Press Releases
Year
Select Year
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
October 8, 2019
Asuragen to Present at the 2019 American Society of Human Genetics (ASHG) Annual Meeting
Share
June 11, 2019
Asuragen to Present at 2019 European Society of Human Genetics (ESHG) Conference
Share
June 4, 2019
Asuragen NGS System Streamlines Detection of NSCLC-associated DNA Mutations, Gene Fusions, and RNA Expression Targets in Single Workflow
Share
April 2, 2019
Asuragen Releases Updated AmplideX® PCR/CE Reporter Software
Share
March 26, 2019
Asuragen to Present at 2019 ACMG Annual Clinical Genetics Meeting
Share
March 19, 2019
Asuragen Portfolio Expansion Continues with Launch of AmplideX® PCR/CE SMN1/2 Kit
Share
January 29, 2019
Asuragen NGS System for Streamlined Detection of RNA Lung Cancer Variants Demonstrates Superior Performance in Multisite Evaluation
Share
January 9, 2019
Asuragen Announces Launch of AmplideX® PCR/CE HTT Kit
Share
December 4, 2018
Asuragen Launches Assay to Aid in the Diagnosis of Myotonic Dystrophy Type I (DM1)
Share
November 13, 2018
Asuragen Announces Health Canada Approval of the QuantideX® qPCR BCR-ABL IS Kit
Share
Prev
1
2
3
4
5
6
7
8
Next
About
About
Leadership Team
Culture and Heritage
Press Releases
Upcoming Events
Business Development
Back To
Top